Document Classification

Section Type: METHODS

Text: One hundred and one patients were randomised to receive either : (i) irinotecan 180 mg/m (2) on day 1 followed by an LV 200 mg/m (2) infusion, before a 5-FU 400 mg/m (2) bolus followed by a 5-FU 600 mg/m (2) infusion (LV5FU2 regimen), on days 1 and 2 every 2 weeks ; (ii) oxaliplatin 85 mg/m (2) on day 1 followed by the LV5FU2 regimen on days 1 and 2 every 2 weeks ; or (iii) oxaliplatin 85 mg/m (2) followed by irinotecan 200 mg/m (2), both on day 1 every 3 weeks.